Vaping illnesses rise to 1,888 in U.S. as pace picks up again

A total of 1,888 confirmed and probable lung injury cases associated with use of e-cigarette, or vaping, products reported in the U.S.

Case total is 284 higher than what the U.S. government reported last week

In this Oct. 4, 2019 photo, a woman loads liquid into her vaping device in Harmony, Pa. Health officials urge people to avoid vaping, particularly products purchased off the street. (Keith Srakocic/Associated Press)

The number of U.S. vaping illnesses has jumped again, reaching more than 1,800 cases.

The U.S. Centers for Disease Control and Prevention said Thursday that 1,888 confirmed and probable cases have been reported in 49 states. That includes 37 deaths in 24 states.

The total is 284 higher than what the government reported last week and a larger increase than seen in several weeks. Officials say the previous slowdown could have been caused by reporting delays.

The outbreak appears to have started in March. No single ingredient, electronic cigarette or vaping device has been linked to all the illnesses. Most who got sick said they vaped products containing tetrahydrocannabinol, or THC, the high-inducing ingredient in marijuana.

Health officials urge people to avoid vaping, particularly products containing THC and purchased off the street.

In Canada, as of Oct. 29, 2019, there are five confirmed or probable cases of severe lung illness related to vaping: two confirmed cases in Quebec, two probable in New Brunswick and one probable in British Columbia. 



To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.